OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
SGLT2 inhibitors: a novel therapy for cognitive impairment via multifaceted effects on the nervous system
Jiaqi Mei, Yi Li, Liyan Niu, et al.
Translational Neurodegeneration (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 12
Jiaqi Mei, Yi Li, Liyan Niu, et al.
Translational Neurodegeneration (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 12
Showing 12 citing articles:
Amyloid-β and heart failure in Alzheimer’s disease: the new vistas
Hayder M. Al‐kuraishy, Ghassan M. Sulaiman, Hamdoon A. Mohammed, et al.
Frontiers in Medicine (2025) Vol. 12
Open Access | Times Cited: 3
Hayder M. Al‐kuraishy, Ghassan M. Sulaiman, Hamdoon A. Mohammed, et al.
Frontiers in Medicine (2025) Vol. 12
Open Access | Times Cited: 3
Use of sodium‐glucose cotransporter‐2 inhibitors and risk of dementia: A population‐based cohort study
Lin Zhuo, Baixue Zhang, Yueqi Yin, et al.
Diabetes Obesity and Metabolism (2025)
Closed Access
Lin Zhuo, Baixue Zhang, Yueqi Yin, et al.
Diabetes Obesity and Metabolism (2025)
Closed Access
Comparative Effectiveness of SGLT2 Inhibitors and GLP-1 Receptor Agonists in Preventing Alzheimer's Disease, Vascular Dementia, and Other Dementia Types Among Patients with Type 2 Diabetes
Mingyang Sun, Xiaoling Wang, Zhongyuan Lu, et al.
Diabetes & Metabolism (2025), pp. 101623-101623
Closed Access
Mingyang Sun, Xiaoling Wang, Zhongyuan Lu, et al.
Diabetes & Metabolism (2025), pp. 101623-101623
Closed Access
Inhibition of repulsive guidance molecule A ameliorates diabetes-induced cognitive decline and hippocampal neurogenesis impairment in mice
Hidehiko Uno, Takahide Itokazu, Toshihide Yamashita
Communications Biology (2025) Vol. 8, Iss. 1
Open Access
Hidehiko Uno, Takahide Itokazu, Toshihide Yamashita
Communications Biology (2025) Vol. 8, Iss. 1
Open Access
Unveiling the mTOR pathway modulation by SGLT2 inhibitors: a novel approach to Alzheimer’s disease in type 2 diabetes
Prakash Ramakrishan, Jayaraman Rajangam, Shaheedha Shabudeen Mahinoor, et al.
Metabolic Brain Disease (2025) Vol. 40, Iss. 3
Closed Access
Prakash Ramakrishan, Jayaraman Rajangam, Shaheedha Shabudeen Mahinoor, et al.
Metabolic Brain Disease (2025) Vol. 40, Iss. 3
Closed Access
Role of mitogen-activated protein kinase inhibitors in Alzheimer's disease: Rouge of brain kinases
Suad Hamdan Almasoudi, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.
Brain Research Bulletin (2025) Vol. 224, pp. 111296-111296
Open Access
Suad Hamdan Almasoudi, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.
Brain Research Bulletin (2025) Vol. 224, pp. 111296-111296
Open Access
The immunomodulatory effects of GLP-1 receptor agonists in neurogenerative diseases and ischemic stroke treatment
Haohui Sun, Yue Hao, Hao Liu, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Haohui Sun, Yue Hao, Hao Liu, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Sodium‐glucose cotransporter‐2 inhibitors and subtype‐specific dementia risk: A multinational and multiethnic cohort study
Mingyang Sun, Xiaoling Wang, Zhongyuan Lu, et al.
Diabetes Obesity and Metabolism (2025)
Closed Access
Mingyang Sun, Xiaoling Wang, Zhongyuan Lu, et al.
Diabetes Obesity and Metabolism (2025)
Closed Access
Cognitive Impairment and Synaptic Dysfunction in Cardiovascular Disorders: The New Frontiers of the Heart–Brain Axis
Teresa Soda, Teresa Pasqua, Giovambattista De Sarro, et al.
Biomedicines (2024) Vol. 12, Iss. 10, pp. 2387-2387
Open Access | Times Cited: 3
Teresa Soda, Teresa Pasqua, Giovambattista De Sarro, et al.
Biomedicines (2024) Vol. 12, Iss. 10, pp. 2387-2387
Open Access | Times Cited: 3
Canagliflozin attenuates neurodegeneration and ameliorates dyskinesia through targeting the NLRP3/Nurr1/GSK-3β/SIRT3 pathway and autophagy modulation in rotenone-lesioned rats
Ahmed M. Abdelaziz, Nora O. Abdel Rasheed, Hala F. Zaki, et al.
International Immunopharmacology (2024) Vol. 146, pp. 113839-113839
Closed Access | Times Cited: 1
Ahmed M. Abdelaziz, Nora O. Abdel Rasheed, Hala F. Zaki, et al.
International Immunopharmacology (2024) Vol. 146, pp. 113839-113839
Closed Access | Times Cited: 1
Empagliflozin Attenuates High-Glucose-Induced Astrocyte Activation and Inflammation via NF-κB Pathway
Dong Hee Kim, Min Jin Lee, Dasol Kang, et al.
Current Issues in Molecular Biology (2024) Vol. 46, Iss. 11, pp. 12417-12427
Open Access
Dong Hee Kim, Min Jin Lee, Dasol Kang, et al.
Current Issues in Molecular Biology (2024) Vol. 46, Iss. 11, pp. 12417-12427
Open Access
The Promising Potency of Sodium–Glucose Cotransporter 2 Inhibitors in the Prevention of and as Treatment for Cognitive Impairment Among Type 2 Diabetes Patients
Yibin Zhang, Xiao-xing Liao, Jialu Xu, et al.
Biomedicines (2024) Vol. 12, Iss. 12, pp. 2783-2783
Open Access
Yibin Zhang, Xiao-xing Liao, Jialu Xu, et al.
Biomedicines (2024) Vol. 12, Iss. 12, pp. 2783-2783
Open Access
SGLT-2 Inhibitors’ and GLP-1 Receptor Agonists’ Influence on Neuronal and Glial Damage in Experimental Stroke
А. В. Симаненкова, Oksana Fuks, Н. В. Тимкина, et al.
Biomedicines (2024) Vol. 12, Iss. 12, pp. 2797-2797
Open Access
А. В. Симаненкова, Oksana Fuks, Н. В. Тимкина, et al.
Biomedicines (2024) Vol. 12, Iss. 12, pp. 2797-2797
Open Access
